Eton Pharmaceuticals (ETON) Net Equity Issued and Repurchased (2019 - 2020)
Eton Pharmaceuticals (ETON) posted Net Equity Issued and Repurchased of $21.0 million for Q4 2020, up 171.09% sequentially from $7.8 million in Q1 2020.
Eton Pharmaceuticals (ETON) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends
Eton Pharmaceuticals has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $21.0 million in Q4 2020.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $21.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $28.8 million (changed N/A YoY) and the FY2020 annual result came in at $28.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $21.0 million in Q4 2020 per ETON's latest filing, from $7.8 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $21.0 million in Q4 2020 and troughed at $77000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.65 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 21.03 Mn |
| Dec 31, 2020 | 21.03 Mn |
| Mar 31, 2020 | 7.76 Mn |
| Mar 31, 2020 | 7.76 Mn |
| Sep 30, 2019 | 77,000.00 |
| Sep 30, 2019 | 77,000.00 |